DiscoverDon Pelto, DPM - Podiatry Practice MasteryKeryFlex, Qutenza & Swift: Profitability, Pitfalls, and Patient Expectations in Podiatry
KeryFlex, Qutenza & Swift: Profitability, Pitfalls, and Patient Expectations in Podiatry

KeryFlex, Qutenza & Swift: Profitability, Pitfalls, and Patient Expectations in Podiatry

Update: 2025-08-28
Share

Description

Some treatments in podiatry look profitable on paper but carry hidden challenges. In this episode, I break down real-world lessons on KeryFlex nail restoration, Qutenza for neuropathy, and Swift therapy for warts—including costs, coding, patient communication, and clinical pearls.


We’ll also dive into my current strategy for Google Business dominance using Swell to multiply reviews across multiple practice and provider listings.


If you’ve ever wondered:

• Is KeryFlex worth the time and learning curve?

• How do I source Qutenza and bill it correctly?

• What’s the best protocol for Swift (blocks, energy settings, and follow-ups)?

• How can Google reviews become a practice-growth engine?


👉 This episode delivers candid answers from the trenches to help you hit the million-dollar mark with clarity and confidence.


Keywords: podiatry practice growth, KeryFlex podiatry, Qutenza podiatry billing, Swift wart therapy podiatry, podiatry Google reviews


00:00 Intro, shoutout, scribe update

00:50 KeryFlex: indications, pricing (kit + per-nail), FAQs & expectations

05:00 Qutenza: sourcing, buy-and-bill vs specialty pharmacy, billing/application flow

08:30 Swift protocol: energy settings, visit cadence, when to pair with cantharidin

12:00 Google review “dominance” with Swell: office vs provider listings, staggered ask

14:30 Rapid clinical pearls + wrap / challenge invite

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

KeryFlex, Qutenza & Swift: Profitability, Pitfalls, and Patient Expectations in Podiatry

KeryFlex, Qutenza & Swift: Profitability, Pitfalls, and Patient Expectations in Podiatry

Don Pelto, DPM